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Abstract 
 CB1- and CB2- type cannabinoid receptors mediate effects of the endocannabinoids 2-
arachidonoylglycerol (2-AG) and anandamide in mammals. In canonical endocannabinoid-mediated 
synaptic plasticity, 2-AG is generated postsynaptically by diacylglycerol lipase alpha and acts via 
presynaptic CB1-type cannabinoid receptors to inhibit neurotransmitter release. Electrophysiological 
studies on lampreys indicate that this retrograde signalling mechanism occurs throughout the 
vertebrates, whilst system level studies point to conserved roles for endocannabinoid signalling in 
neural mechanisms of learning and control of locomotor activity and feeding. CB1/CB2-type 
receptors originated in a c mmon ancestor of extant chordates, and in the sea squirt Ciona 
intestinalis a CB1/CB2-type receptor (CiCBR) is targeted to axons, indicative of an ancient role for 
cannabinoid receptors as axonal regulators of neuronal signalling. Although CB1/CB2-type receptors 
are unique to chordates, enzymes involved in biosynthesis/inactivation of endocannabinoids occur 
throughout the animal kingdom. Accordingly, non-CB1/CB2-mediated mechanisms of 
endocannabinoid signalling have been postulated. For example, there is evidence that 2-AG mediates 
retrograde signalling at synapses in the nervous system of the leech Hirudo medicinalis by activating 
presynaptic TRPV-type ion channels. Thus, postsynaptic synthesis of 2-AG or anandamide may be a 
phylogenetically widespread phenomenon, and a variety of proteins may have evolved as 
presynaptic (or postsynaptic) receptors for endocannabinoids. 
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1. PREFACE 
 On March 29th 2001 a review titled “The Neurobiology and Evolution of Cannabinoid 
Signalling” was published in Philosophical Transactions of the Royal Society B (1).  It was the first 
review on cannabinoid signalling to be published in this journal. Since then the field of research on 
cannabinoid signalling has grown exponentially. Accordingly, the present article is one of fourteen 
reviews that collectively form an entire journal issue devoted to “Endocannabinoids in nervous 
system health and disease”. Writing of the 2001 review required a survey of approximately 3000 
articles, which was challenging but feasible. Ten years later, by the end of 2011, the PubMed 
database had over 11,000 articles that could be found using the search term “cannabinoid*”. Clearly, 
it is no longer feasible to comprehensively review this field of research in a journal article. Even a 
large book devoted to cannabinoid biology could not cover the range of papers on this topic. 
Therefore, it is necessary in a review such as this to focus on a specific aspect of cannabinoid 
biology and the theme here is “The Evolution and Comparative Neurobiology of Endocannabinoid 
Signalling”, focusing largely on articles that have been published since 2001. 
 In discussing the evolution and comparative neurobiology of endocannabinoid signalling, it 
is necessary to first provide an overview of current understanding of mechanisms of 
endocannabinoid signalling in the group of animals in which this system was discovered – the 
mammals. It is fitting therefore that on March 29th 2001, three landmark experimental papers were 
also published that transformed our understanding of endocannabinoid signalling in the mammalian 
nervous system. Independently, three research groups obtained evidence that postsynaptic 
depolarisation of principal neurons in the hippocampus or cerebellar cortex triggers postsynaptic 
synthesis of endocannabinoids, which then act presynaptically to cause CB1-mediated inhibition of 
neurotransmitter release (2-4) Thus, a mechanism of synaptic plasticity mediated by retrograde 
endocannabinoid signalling was discovered. The concept that endocannabinoids might act as 
retrograde synaptic signalling molecules had been proposed three years earlier based on our 
neuroanatomical observations (5) and a model of this putative signalling mechanism was presented 
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in the 2001 review article (1). But it was the three other papers published on the 29th March 2001 
that converted a hypothesis into a textbook principle. Within a decade, the field of research on 
endocannabinoid signalling has moved from a marginal position to the centre stage of 21st century 
neuroscience. So looking back, the 29th March 2001 can be thought of as a turning point for 
cannabinoid research and indeed it has been referred to as a Dies Mirabilis for the field (6). 
 
2. INTRODUCTION TO ENDOCANNABINOID SIGNALLING 
 
(a) Discovery of CB1 and CB2 cannabinoid receptors    
 The existence of cannabinoid receptors in the brain was first inferred from the stereoselective 
pharmacological actions of ∆9-tetrahydrocannabinol (∆9-THC), the psychoactive constituent of 
cannabis, and other cannabinoid-type compounds (7). However, demonstration of the existence of 
specific cannabinoid binding sites in the brain using the radiolabelled cannabinoid 3H-CP-55,940 
provided the first solid evidence that cannabinoid receptors exist in the brain (8). Molecular 
characterisation of a protein that confers cannabinoid binding-sites on rodent brain cell membranes 
provided the definitive proof of a receptor and revealed a 473-residue G-protein coupled receptor 
(9), which is now referred to as CB1. This nomenclature distinguishes CB1 from a related G-protein 
coupled receptor known as CB2, which is predominantly associated with immune cells (10). Thus, in 
humans and other mammals there are two G-protein coupled cannabinoid receptors, CB1 and CB2, 
and analysis of CB1-knockout mice and CB2-knockout mice indicates that these two receptors are 
largely responsible for mediating the pharmacological effects of ∆9-THC in mammals (11-13). 
 
(b) Endocannabinoids and enzymes involved in endocannabinoid biosynthesis and inactivation  
 The discovery of CB1 and CB2 pointed to the existence of endogenous ligands for these 
receptors and two such “endocannabinoids” have been identified – N-arachidonoylethanolamide 
(“anandamide”) and sn-2-arachidonoylglycerol (2-AG) (14-16).  
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2-AG is synthesized in the brain by the enzyme diacylglycerol lipase alpha (DAGLα), which 
catalyses cleavage of 2-AG from arachidonic acid containing diacylglycerols (DAGs) (17-19). A 
second diacylglycerol lipase that is related to DAGLα based on sequence similarity has been 
identified and is known as DAGLβ (17). However, whilst DAGLβ can catalyse formation of 2-AG 
in vitro (17), comparative analysis of the brain content of 2-AG in DAGLα- and DAGLβ-knockout 
mice indicates that the contribution of DAGLβ to 2-AG biosynthesis in adult brain is much less 
significant compared to DAGLα (18, 19). 2-AG is inactivated by the enzyme monoacylglycerol 
lipase (MAGL), which cleaves 2-AG into arachidonic acid and glycerol (20-22). Approximately 
85% of brain 2-AG hydrolase activity is attributable to MAGL, whilst the remaining 15% is largely 
attributed to the α/β hydrolases ABH6 and ABH12 (23). 
The mechanisms by which anandamide is synthesized in the brain are not yet fully 
characterised. In vitro studies suggested that anandamide may be synthesized by a two-step 
enzymatic pathway wherein a Ca2+-activated N-acyltransferase transfers a sn-1 arachidonoyl acyl 
group of a phospholipid onto the amine of phosphatidylethanolamine (PE) to generate N-acyl PE 
(NAPE) and then NAPE is converted by a phospholipase D (NAPE-PLD) into anandamide and 
phosphatidic acid (24-27). However, the levels of anandamide in brains from NAPE-PLD-knockout 
mice are not significantly different from wild-type mice, arguing against a role for NAPE-PLD in 
anandamide biosynthesis in the brain. The levels of long-chain saturated N-acylethanolamines are 
substantially reduced in NAPE-PLD knockout mice though, indicating that the primary function of 
NAPE-PLD in the brain may be in biosynthesis of these molecules (28). The physiological roles of 
long-chain saturated N-acylethanolamines in the brain are unknown, but localisation of NAPE-PLD 
in the axons and axon terminals of sub-populations of neurons in the brain has provided a 
neuroanatomical framework for further investigation of this issue (29). 
Other enzymatic pathways have also been implicated in biosynthesis of anandamide (30-35) 
but, as yet, definite proof that these are involved in in vivo production of anandamide in the brain has 
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not been forthcoming. It is possible that multiple and potentially interacting pathways are involved, 
which may make it difficult to pinpoint roles for particular enzymes.   
Whilst our knowledge of mechanisms of anandamide biosynthesis in the brain remains 
incomplete, enzymes that catalyse inactivation of anandamide have been identified. In 1996 Cravatt 
et al. identified an enzyme known as fatty acid amide hydrolase (FAAH), which converts 
anandamide to arachidonic acid and ethanolamine (36) and subsequent analysis of FAAH knockout-
mice and mice treated with selective FAAH inhibitors have demonstrated that FAAH has a major 
role in regulation of anandamide levels in the brain (37, 38). In humans, but not rodents, there is a 
second FAAH-like enzyme, which is known as FAAH-2 (39). Analysis of the biochemical properties 
of FAAH-2 reveals that it associated with lipid droplets in cells and hydrolyses anandamide at rates 
30-40% of those of FAAH (40). Furthermore, cyclooxygenase-2 (COX-2) also contributes to the 
metabolism of anandamide in neurons and other cell types (41, 42). 
Lastly, evidence for and against the existence of proteins involved in transport of 
endocannabinoids has been reported (43, 44) and recently it was proposed that a catalytically silent 
isoform of FAAH (FAAH-like anandamide transporter or FLAT) may drive anandamide transport 
into neurons (45). 
 
(c) Putative regulators of cannabinoid receptor signalling  
The existence of proteins that regulate the activity of G-protein coupled receptors (GPCRs) is 
well established. These include proteins such as G-protein coupled receptor kinases (GRKs), which 
phosphorylate serine and threonine residues in GPCR C-terminal of tails following G-protein 
dissociation, and arrestins, which bind to C-terminally phosphorylated GPCRs and then block 
interaction with G-proteins and mediate receptor internalisation (46). However, these are generic 
GPCR-interacting proteins that regulate the activity of many GPCRs. In addition to these generic 
GPCR-interacting proteins, other proteins that only interact with specific GPCRs have been 
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identified. For example, the melanocortin receptor accessory protein MRAP mediates targeting of 
MC2-type melanocortin receptors to the cell surface in adrenal cells (47-49). 
 The first report of candidate cannabinoid receptor interacting proteins (CRIPs) was published 
in 2007 (50). Deletion of the C-terminal region of the CB1 receptor had been found to alter CB1 
signalling (51) and it was postulated that accessory proteins binding to this region of the receptor 
may modulate CB1 activity. Using a polypeptide corresponding to the C-terminal 55 residues of the 
CB1 receptor as bait, a yeast two-hybrid screen was employed to identify potential interacting partner 
proteins expressed in human brain. A 128 residue protein was identified as a positive hit and analysis 
of its sequence revealed that it is encoded by a gene containing four exons (1, 2, 3a and 3b) that is 
subject to alternative splicing, with exons 1, 2 and 3b encoding the 128 residue protein and exons 1, 
2 and 3a encoding a 164 residue protein (50). Biochemical evidence that both the 164-residue 
protein and the 128-residue protein interact with the C-terminal tail of CB1 was obtained and 
accordingly these two proteins were named cannabinoid receptor interacting protein 1a (CRIP1a) 
and cannabinoid receptor interacting protein 1b (CRIP1b), respectively. Furthermore, co-expression 
of CRIP1a or CRIP1b with CB1 in superior cervical ganglion neurons revealed that CRIP1a, but not 
CRIP1b, suppresses CB1-mediated tonic inhibition of voltage-gated Ca2+ channels, providing 
evidence of a role for CRIP1a in regulation of CB1 signalling (50). More recently, it has been 
reported that co-expression of CRIP1a with CB1 receptors in cultured cortical neurons alters the 
actions of cannabinoids in a neuroprotection assay, inhibiting the neuroprotective effect of a CB1 
agonist (WIN55,212-2) and conferring responsiveness to the CB1 antagonist SR141716 as a 
neuroprotective agent (52). These data provide further evidence that CRIP1a may regulate CB1 
signalling. However, as yet, evidence that CRIP1a regulates CB1 signalling in vivo has not been 
reported and for this we may have to await the characterisation of CRIP1a gene-knockout mice. 
 
(d) Endocannabinoid signalling as a mediator of synaptic plasticity in the nervous system  
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 Thus far, a catalogue of proteins that act as cannabinoid receptors or regulators of 
cannabinoid receptor signalling or catalyse biosynthesis/inactivation of endocannabinoids has been 
presented. However, from a neurobiological perspective our interest is in understanding how these 
proteins work together at the cellular level to enable neurophysiological mechanisms to operate. The 
term “cannabinoid or endocannabinoid signalling” first appears in the literature in 1998 (53, 54) but 
prior to this much was already known about the distribution of the CB1 receptor in the brain and the 
effects of cannabinoids on neurotransmitter release. Based on an analysis of the distribution 
cannabinoid binding sites (using 3H-CP-55,940 autoradiography) combined with lesion studies and 
analysis of patterns of CB1 gene expression (using mRNA in situ hybridisation) it was concluded 
that the CB1 receptor is targeted to the axons and axon terminals of neurons in the brain (55-58). 
This was then confirmed by a series of immunocytochemical studies published in 1998 (5, 59, 60). 
This presynaptic targeting of CB1 receptors in neurons was consistent with electrophysiological 
studies demonstrating that cannabinoids cause inhibition of neurotransmitter release (61). 
Furthermore, evidence that endocannabinoids are released in response to neuronal stimulation was 
reported (62), which suggested that endocannabinoids act as intercellular (not intracellular) 
signalling molecules. A logical extrapolation of these anatomical and physiological observations was 
that endocannabinoids are synthesized postsynaptically and act as retrograde synaptic signalling 
molecules (5), which was subsequently proven to be correct. 
Depolarisation of principal neurons in several brain regions causes CB1-mediated inhibition 
of presynaptic release of the excitatory neurotransmitter glutamate (depolarisation-induced 
suppression of excitation or DSE) and/or CB1-mediated inhibition of presynaptic release of the 
inhibitory neurotransmitter GABA (depolarisation-induced suppression of inhibition or DSI) (2-4). 
DSE and DSI are not observed in DAGLα-knockout mice, indicating that 2-AG mediates these 
mechanisms of synaptic plasticity (18, 19). DAGLα is concentrated postsynaptically in dendritic 
spines that are apposed to CB1-expressing axon terminals (63), which is consistent with the notion 
that 2-AG is synthesized postsynaptically but acts presynaptically. The 2-AG degrading enzyme 
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MAGL is localised presynaptically in the axons of neurons, most notably in glutamatergic neurons 
(20, 64) and the duration of DSI and DSE in MAGL-knockout mice is prolonged when compared to 
wild-type mice, indicating that MAGL controls the temporal dynamics of 2-AG/CB1-mediated 
retrograde synaptic signalling (65, 66). Accordingly, the MAGL inhibitor JZL184 also prolongs the 
duration of DSI and DSE in mice (67).  
  Endocannabinoid signalling also mediates long-term depression (LTD) of synaptic 
transmission. For example, stimulation of cortical glutamatergic input to the striatum causes 
activation of postsynaptic metabotropic glutamate receptors, leading to endocannabioid/CB1-
mediated long-term depression of transmission at excitatory cortico-striatal synapses (68). 
Endocannabioid/CB1–mediated LTD has subsequently been reported in other brain regions and there 
is evidence that, as with DSE and DSI, it is postsynaptic formation of 2-AG that mediates this 
particular form of long-term synaptic plasticity (69). 
The physiological roles of anandamide as an endogenous agonist for CB1 receptors in the 
central nervous system are currently less well characterised when compared to 2-AG. Evidence that 
anandamide may also mediate retrograde signalling at synapses has also been reported (70) and it 
has been suggested that anandamide may mediate tonic endocannabinoid signalling, thereby 
performing a role that is distinct from the transient stimulated release of 2-AG (71). Furthermore, 
there is evidence that anandamide may mediate mechanisms of synaptic plasticity via CB1-
independent molecular pathways. Thus, postsynaptic elevation of intracellular anandamide levels is 
thought to cause LTD via a mechanism mediated by the cation channel TRPV1, which results in 
internalisation of postsynaptic AMPA-type glutamate receptors (6, 70, 72).  
 Whilst our knowledge and understanding of the roles of endocannabinoid signalling at the 
synaptic level have improved dramatically over the last decade, there is still much work to be done 
in linking processes at this level to the systems level. The CB1 receptor is widely distributed in the 
brain but not all neurons express CB1, so why do particular neural pathways in the brain utilise 
endocannabinoid signalling to regulate synaptic transmission, whilst others don’t. Proximate answers 
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 10
to this question will surely emerge as we learn more about the patterns of electrical activity that 
trigger synthesis of endocannabinoids in different regions of the brain and the net behavioural 
consequences of this. However, ultimate answers will only be obtained by comparative analysis of 
the physiological roles of the endocannabinoid system, which may shed light on how over 
evolutionary timescales the endocannabinoid system has been recruited as a regulator of neural 
processes in different lineages. Some roles of the endocannabinoid system in brain function may be 
ancient and highly conserved; other roles may have evolved more recently as neural adaptations that 
are unique to particular lineages. If we are to understand endocannabinoid signalling it will be 
necessary to explore the physiological roles of this system throughout the animal kingdom, and 
already important insights are beginning to emerge from comparative studies on non-mammalian 
animals, as discussed below. 
 
3. THE PHYLOGENETIC DISTRIBUTION AND EVOLUTION OF ENDOCANNABINOID 
SIGNALLING  
 
 Canonical endocannabinoid signalling in the mammalian nervous system, as it is currently 
understood, could be characterised as a process in which postsynaptic formation of 2-AG by 
DAGLα in response to depolarisation-induced Ca2+ elevation or activation of metabotropic receptors 
coupled via G-proteins to PLC causes inhibition of neurotransmitter release when 2-AG binds to 
presynaptic CB1 receptors, with the spatial and temporal dynamics of this signalling mechanism 
being controlled by presynaptic degradation of 2-AG by MAGL. Thus, in investigating the 
evolutionary origins of endocannabinoid signalling, one could specifically investigate the 
phylogenetic distribution DAGLα, MAGL and CB1-type receptors. However, this would be a rather 
narrowly defined view of endocannabinoid signalling in the nervous system. It is true to say that at 
present our understanding of the physiological role of anandamide as an endogenous ligand for CB1   
receptors is incomplete by comparison with 2-AG. Nevertheless, the phylogenetic distribution of 
Page 10 of 40
http://mc.manuscriptcentral.com/issue-ptrsb
Submitted to Phil. Trans. R. Soc. B - Issue
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Evolution and Comparative Neurobiology  Maurice R. Elphick  
 
 11
enzymes involved or implicated in anandamide biosynthesis or inactivation is of interest. Likewise, 
it is important to investigate the phylogenetic distribution of proteins implicated as regulators of CB1   
signalling such as CRIP1a and CRIP1b, because this may inform understanding of their proposed 
functions. Whilst CB1 is by far the most abundant cannabinoid receptor in the mammalian nervous 
system, there is evidence that CB2 may have important roles in neural functions (73) and therefore 
the phylogenetic distribution of CB2 receptors is also of interest from a neurobiological perspective. 
 
(a) The phylogenetic distribution of CB1/CB2-type cannabinoid receptors 
 As mediators of the pharmacological effects of ∆9-THC and the physiological actions of 
endocannbinoids, the G-protein coupled cannabinoid receptors CB1 and CB2 are the focal points for 
a phylogenetic survey of endocannabinoid signalling. CB1 and CB2 share more sequence similarity 
with each other (~44%) than with any other mammalian G-protein coupled receptors, indicating that 
they originated by duplication of a common ancestral gene (i.e. they are paralogs). Furthermore, the 
relatively low level of sequence similarity shared by CB1 and CB2 receptors in mammals is 
suggestive of an evolutionarily ancient gene duplication. Analysis of the phylogenetic distribution of 
CB1 and CB2 receptors indicates that the gene duplication that gave rise to these two receptors 
occurred in a common ancestor of extant vertebrates, probably concurrently with a whole-genome 
duplication event. Thus, CB1 and CB2 receptor genes can be found in the genomes of non-
mammalian tetrapod vertebrates (amphibians e.g. Xenopus tropicalis; birds e.g. Gallus gallus) and in 
bony fish (e.g. the zebrafish Danio rerio) (74, 75). Interestingly, in teleosts duplicate copies of CB1 
or CB2 genes are found, attributable to a genome-duplication in a common ancestor of teleosts 
followed by subsequent lineage-specific retention/loss of duplicate genes. Thus, in the zebrafish 
Danio rerio there is one CB1 gene and two CB2 genes, whereas in the puffer fish Fugu rubripes there 
are two CB1 genes and one CB2 gene. However, the functional significance of the differential 
retention of duplicate CB1 or CB2 genes in different teleost lineages is currently unknown (74, 75). 
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 To date there are no published reports of CB1 and CB2 genes in the most basal of the extant 
vertebrate orders – the chondrichthyes (e.g. sharks and rays) and the agnathans (e.g. lampreys and 
hagfish). However, unpublished genome sequence data are available for the elephant shark 
Callorhinchus milii (http://esharkgenome.imcb.a-star.edu.sg/) and the sea lamprey Petromyzon 
marinus (http://genome.wustl.edu/genomes/view/petromyzon_marinus) and in both species a gene 
encoding a CB1-type receptor can be found. Interestingly, a CB2-type receptor gene is not evident in 
the currently available genome sequence data, which may simply reflect incomplete sequence data or 
perhaps more interestingly may reflect loss of CB2 receptor genes in these basal vertebrates. 
 Genes encoding CB1/CB2-type receptors have been found in the invertebrate groups that are 
most closely related to the vertebrates (urochordates, e.g. CiCBR in Ciona intestinalis; 
cephalochordates, e.g. BfCBR in Branchiostoma floridae) but not in the non-chordate invertebrate 
phyla (74, 76-79). Thus, it appears that CB1/CB2-type receptors are unique to the phylum Chordata 
and as such they have a rather restricted phylogenetic distribution in the animal kingdom.  
 
(b) The phylogenetic distribution of DAG lipases 
 The antiquity of DAG lipases is evident in the strategy that led to the discovery of the 
mammalian enzymes DAGLα and DAGLβ - the sequence of a DAG lipase originally identified in 
the bacterium Penicillium was used to identify related proteins in BLAST searches of the human 
genome sequence (17). This indicates that DAG lipases are an ancient enzyme family that originated 
in prokaryotes. Submission of human DAGLα and human DAGLβ as query sequences in BLAST 
searches of the GenBank protein database reveals orthologs of both isoforms in deuterostomian 
invertebrates and protostomian invertebrates. Thus, the gene duplication that gave rise to DAGLα or 
DAGLβ dates back at least as far as the common ancestor of extant bilaterian animals.  
 
(c) The phylogenetic distribution of MAG lipase 
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 MAG lipase (MAGL) was originally discovered on account of its role in fat metabolism (80) 
and subsequently it was proposed that MAGL may regulate 2-AG levels in the brain (20). 
Submission of human MAGL as a query sequence in BLAST searches of the GenBank protein 
database reveals orthologs in a wide range of animal species, including deuterostomian invertebrates, 
protostomian invertebrate and basal invertebrates such as cnidarians (Nematostella vectensis) and 
placozoans (Trichoplax adhaerens). Therefore, MAGL was present in the common ancestor of 
extant animals. However, there has been loss of MAGL in some lineages; for example, in 
Drosophila and other insects. Interestingly, MAGL is also found in poxviruses, which is probably a 
consequence of horizontal gene transfer from host species (81). 
 
(d) The phylogenetic distribution of NAPE-PLD as an enzyme implicated in anandamide 
biosynthesis 
 Although analysis of NAPE-PLD knockout mice indicates that NAPE-PLD is not responsible 
for synthesis of the bulk of anandamide in the brain (28), this does not rule out the possibility that 
NAPE-PLD participates in anandamide biosynthesis in other organs and organisms. Therefore, it is 
of interest to determine the phylogenetic distribution of NAPE-PLD with respect to the evolution of 
endocannabinoid signalling. Orthologs of NAPE-PLD are found throughout the animal kingdom, in 
non-mammalian vertebrates, deuterostomian invertebrates (e.g. the sea urchin Strongylocentrotus 
purpuratus), protostomian invertebrates (e.g. the crustacean Daphnia pulex and the nematode C. 
elegans) and basal invertebrates such as the cnidarian Nematostella vectensis and the placozoan 
Trichoplax adhaerens. However, as with MAGL, there has been loss of NAPE-PLD in some 
lineages. For example, orthologs of NAPE-PLD are not present in Drosophila and other insects, the 
urochordate Ciona intestinalis and the cephalochordate Branchiostoma floridae. The functional 
significance of NAPE-PLD loss in some animal lineages is currently unknown. However, 
biochemical analysis of species that lack NAPE-PLD may provide useful new insights on NAPE-
PLD-independent mechanisms of N-acylethanolamine biosynthesis.     
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(e) The phylogenetic distribution of FAAH and FAAH-2 
 Analysis of the phylogenetic distribution of FAAH and FAAH2 indicates that the gene 
duplication that gave rise to these related proteins probably predates the origins of the first animals 
with nervous systems. However, in addition to the loss of FAAH2 in rodents (see above), there are 
other examples of lineage-specific loss of FAAH or FAAH2. For example, only a FAAH2 ortholog 
is found in Drosophila and other insects.  
  
(f) The phylogenetic distribution of CRIP1a and CRIP1b 
Analysis of the phylogenetic distribution of CRIP1a and CRIP1b in mammals reveals that, 
whilst CRIP1a is found throughout the mammals, CRIP1b may be unique to catarrhine primates. For 
example, orthologs of human CRIP1b can be found in the chimpanzee Pan troglodytes, the gibbon 
Nomascus leucogenys and the rhesus monkey Macaca mulatta. Thus, it appears that exon 3b of the 
human CRIP1 gene, which is unique to CRIP1b, may have originated relatively recently in 
mammalian evolution. The functional significance of this is unknown and it will be interesting to 
investigate the roles of CRIP1b in brain function. 
Unlike the restricted phylogenetic distribution of CRIP1b, CRIP1a has a much wider 
phylogenetic distribution that extends throughout much of the animal kingdom. Indeed orthologs of 
CRIP1a can be found in basal invertebrates such as the cnidarian Nematostella vectenses, indicating 
that CRIP1a is very ancient protein with origins dating back to the first animals with nervous 
systems. Accordingly, orthologs of human CRIP1a are found throughout the vertebrates and in 
deuterostomian invertebrates (e.g. in the cephalochordate Branchiostoma floridae and in the 
hemichordate Saccoglossus kowalevski) and protostomian invertebrates (e.g. in the insect Bombus 
impatiens and in the nematode Caenorhabditis elegans). This contrasts with the much more 
restricted phylogenetic distribution of CB1/CB2-type cannabinoid receptors, which, as highlighted 
above, are only found in vertebrates and invertebrate chordates. What this suggests is that CRIP1a is 
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evolutionarily much more ancient than the CB1 receptor protein that it is thought to interact with. We 
can infer from this that CRIP1a must have other physiological roles in cells in addition to its 
proposed interaction with CB1 receptors. 
 
 
4. COMPARATIVE NEUROBIOLOGY OF ENDOCANNABINOID SIGNALLING 
 
(a) Neurobiology of CB1/CB2-type endocannabinoid signalling in non-mammalian vertebrates
 Given that a great deal is now known about the role of endocannabinoid-CB1 signalling in 
mediating retrograde signalling at synapses in the mammalian brain, it is pertinent to pose the 
question: is there evidence that endocannabinoid-CB1 mediated retrograde signalling operates at 
synapses in the central nervous systems of non-mammalian vertebrates? Addressing this question 
may shed light on the evolutionary origin of this particular mechanism of synaptic plasticity. Not 
surprisingly, direct evidence from electrophysiological studies comparable to those carried out on 
rodent brain slices is sparse. The strongest evidence can be found in an impressive series of studies 
investigating the roles of endocannabinoid signalling in the spinal neuronal network that controls 
swimming in the lamprey Lampetra fluviatilis. Collectively, the data obtained indicate that 2-AG is 
synthesized postsynaptically by neurons in the spinal locomotor network and acts presynaptically to 
inhibit both excitatory and inhibitory neurotransmission via CB1-mediated mechanisms. 
Furthermore, nitric oxide and endocannabinoid signalling interact to regulate the 
frequency/amplitude of the locomotor rhythm by differentially modulating excitatory and inhibitory 
inputs to motoneurons (82-85). Thus, it appears that 2-AG/CB1-mediated regulation of excitatory 
and inhibitory neurotransmission is a highly conserved mechanism throughout the vertebrates. 
Consistent with this hypothesis, recent electrophysiological studies have demonstrated that 
endocannabinoid-CB1 signalling mediates DSE and metabotropic glutamate receptor - induced LTD 
in area X of the zebra finch brain (Thompson and Perkel, 2011). Furthermore, immunocytochemical 
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analysis of CB1   expression in the nervous systems of non-mammalian vertebrates reveals patterns 
of expression consistent with axonal targeting and presynaptic sites of action (86-89). 
Given the key role that DAGLα has in postsynaptic formation of 2-AG as a mediator of 
retrograde synaptic signalling in the mammalian CNS, it would be interesting to determine whether 
DAGLα is located in the somatodendritic compartment of neurons postsynaptic to CB1-expressing 
axons in non-mammalian vertebrates. However, whilst the existence of DAGLα in non-mammalian 
vertebrates is confirmed by comparative analysis of genome sequence data (see above), detailed 
neuroanatomical analyses of DAGLα expression in the CNS of non-mammalian vertebrates have not 
yet been conducted. 
 It is perhaps not surprising that the physiological roles of 2-AG/CB1-mediated 
endocannabinioid signalling at the sub-cellular/cellular level are conserved throughout the 
vertebrates. Are, however, the roles of endocannabinoid signalling also conserved at the system level 
e.g. with respect to the regions of the CNS where the CB1 receptor is expressed and the 
physiological/behavioural processes that the endocannabinoid signalling system regulates? To 
address this question, we must look to a currently rather limited number of neuroanatomical and 
behavioural studies of the cannabinoid system in non-mammalian vertebrates. 
 Developmental analysis of the zebrafish Danio rerio reveals CB1 mRNA expression in cells 
located in the presumptive preoptic area of the diencephalon at 24 hours post-fertilization (pf) and by 
48 hours expression is observed in the telencephalon, the hypothalamus, the tegmentum and the 
hindbrain (ventral to cerebellum). In adult zebrafish, CB1 mRNA expression is observed in the 
anterior region of the telencephalon and in the periventricular medial zone and central zone of the 
dorsal telencephalon. Expression is also evident in the hypothalamus and posterior tuberculum 
(diencephalon) and in the torus longitudinalis (mesencephalon) (90). Complementing the use of in 
situ hybridisation techniques by Lam et al. for analysis of CB1 mRNA expression in Danio rerio, 
Cottone et al. have used immunocytochemical techniques to investigate the distribution of the CB1 
protein in the cichlid Pelvicachromis pulcher (86, 91). Immunostained neurons and/or fibres were 
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observed in several brain regions including the telencephalon, the preventricular preoptic nucleus, 
the lateral infundibular lobes of the hypothalamus, the pretectal central nucleus and the posterior 
tuberculum. 
In amphibians, the distribution of CB1 mRNA in the brain of the rough skinned newt Taricha 
granulosa has been examined using mRNA in situ hybridisation methods, revealing a widespread 
pattern of expression with CB1 mRNA detected in the telencephalon (olfactory bulb, the pallium and 
amygdala), the diencephalon (preoptic area and thalamus), the mesencephalon (tegmentum and 
tectum) and the hindbrain (cerebellum and stratum griseum) (92). Complementing the use of in situ 
hybridisation techniques by Hollis et al. for analysis of CB1 mRNA expression in Taricha, Cesa et 
al. have used immunocytochemical techniques to investigate the distribution of CB1   in the brain of 
Xenopus leavis, revealing CB1-immunoreactive cells and/or fibres in the olfactory bulbs, dorsal and 
medial pallium, striatum, amygdala, thalamus, hypothalamus, mesencephalic tegmentum and 
cerebellum (87). CB1-immunoreactivity is also present in the dorsal and central fields of the Xenopus 
spinal cord, regions that correspond to laminae I-IV and X of the mammalian spinal cord (88). 
 In birds, CB1 expression has been analysed in the brain of the chick Gallus gallus (93), the 
zebra finch Taeniopygia guttata (89) and the budgerigar Melopsittacus undulates (94), revealing 
some patterns of expression that are strikingly similar to findings in mammals (57, 95). For example, 
high levels of CB1 expression are observed in the hippocampus and amygdala and, as in mammals, 
in the cerebellar cortex the CB1 gene is expressed in granule cells and the receptor protein is targeted 
to parallel fibres in the molecular layer. 
 Detailed descriptions of the distribution of CB1 receptor expression in the CNS provide 
valuable frameworks for further investigation of the roles of the endocannabinoid signalling system 
in non-mammalian vertebrates. However, the number of species analysed thus far are too few to 
enable any meaningful general conclusions on how the neuroarchitecture the cannabinoid signalling 
system has been shaped by lineage-specific changes in brain organisation over evolutionary time 
scales. Nevertheless, the expression of CB1 in so many different brain regions suggests that 
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endocannabinoid signalling has been a fundamental and widely employed mechanism of synaptic 
plasticity throughout more than 400 million years of vertebrate brain evolution. Moreover, there is 
evidence that at least some of the physiological/behavioural roles of endocannabinoid signalling that 
have been discovered in mammals are also applicable to non-mammalian vertebrates, suggesting 
evolutionarily ancient origins. 
Some of the most striking actions of CB1 cannabinoid receptor agonists in mammals are 
dose-dependent modulatory effects on locomotor activity (96). These behavioural effects are 
consistent with abundant expression of the CB1 receptor in brain regions involved in initiation (basal 
ganglia) and co-ordination (cerebellum) of movement (1). Furthermore, consistent with the notion 
that CB1 has an evolutionarily ancient role in neural pathways that control movement, Valenti et al. 
have reported that the CB1 receptor antagonist AM 251 (1µg/g body mass) causes a reduction in 
locomotor activity in the goldfish Carassius auratus (97). Behavioural effects of drugs that bind to 
the CB1 receptor have also been investigated in an amphibian species, the rough skinned newt 
Taricha granulosa, revealing an inhibitory effect on spontaneous locomotor activity and courtship 
clasping behaviour (98). Likewise, the cannabinoid WIN 55,212-2 causes inhibition of locomotor 
activity in the zebra finch (99). 
The brain endocannabinoid system is also involved in regulation of appetite and feeding in 
mammals (100), and again there is evidence that this role may be evolutionarily ancient. A study by 
Valenti et al. on the goldfish Carassius auratus found that food deprivation was accompanied by a 
significant increase in anandamide (but not 2-AG) in the telencephalic region of the brain and 
intraperitoneal injection of anandamide (1 pg/g body mass) caused an increase in food intake within 
2 h of administration (97). Soderstrom et al. report that in the zebra finch a reduction in food 
availability causes elevation of 2-AG in the caudal telecephalon and a CB1-mediated reduction in 
song-stimulated brain expression of the transcription factor ZENK and a CB1-mediated reduction in 
singing (101). Thus, the endocannabinoid system may have a fundamental role in linking 
behavioural activity with food availability.  
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The endocannabinoid signalling system is also involved in mechanisms of learning and 
memory and studies on rodent models have, for example, provided evidence of roles in mechanisms 
of synaptic plasticity in brain regions critical for declarative memory (hippocampus) and in neural 
mechanisms underlying extinction of aversive memories (102). In this aspect of endocannabinoid 
signalling, research on a non-mammalian vertebrate, the zebra finch Taeniopygia guttata, has been 
particularly significant. The zebra finch is an attractive model system for research on neural 
mechanisms of learning because, in a manner analogous to human language acquisition, male zebra 
finches learn a song pattern during juvenile development (103). Ken Soderstrom and colleagues have 
found that cannabinoid exposure during sensorimotor stages of vocal development alters song 
patterns produced later during adulthood (104) with distinct sub-periods of sensitivity (105). 
Consistent with these findings, the CB1 receptor is expressed in brain regions involved in song 
learning (89) and song production (106), with cannabinoid exposure during sensorimotor stages of 
vocal development leading to alterations in CB1 expression and 2-AG levels in the adult brain (107). 
Further investigation of mechanisms of action have revealed that cannabinoid exposure during 
sensorimotor stages of vocal development leads to increased basal expression of the transcription 
factor FoxP2 in the striatum of adult birds, including the area X song region (108) and increased 
dendritic spine densities (109). 
Analysis of the effects of cannabinoids on adult zebra finches reveals an inhibitory effect on 
song production (110) and an associated inhibition of expression of the transcription factor ZENK in 
a brain region that is involved in auditory perception (the caudomedial neostriatum) (111). Adult 
exposure to cannabinoids also causes dose-related inhibitory or stimulatory effects on neuronal 
activity (based on c-fos expression) in brain regions that control vocal motor output (112). 
Thus far, the zebra finch cannabinoid studies have focused primarily on the effects of 
exogenous cannabinoids (in particular WIN 55,212-2) on song learning and song production. This 
has provided insights on how developmental exposure to cannabinoids can lead to permanent 
alterations in brain function and behaviour, which may be highly relevant to an understanding of the 
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risks associated with cannabis use in adolescents (113). With the recent development of drugs that 
selectively inhibit degradation of endocannabinoids (e.g. the MAGL inhibitor JZL184 and the 
FAAH inhibitor PF-3845), it may now be possible to obtain more insights on the physiological roles 
of the endocannabinoid signalling system in learning using the zebra finch as a model system. 
 
(b) Neurobiology of CB1/CB2-type endocannabinoid signalling in invertebrate chordates 
 As highlighted above, the discovery of genes encoding co-orthologs of CB1 and CB2 in the 
urochordate Ciona intestinalis (CiCBR) (77) and in the cephalochordate Branchiostoma floridae 
(BfCBR) (76) revealed that the evolutionary origin of CB1/CB2-type cannabinoid receptors could be 
traced back beyond the vertebrates to the common ancestor of extant chordates. As of yet the 
pharmacological properties of CiCBR and BfCBR have not been determined and although these 
receptors are clearly CB1/CB2-type receptors based on sequence similarity, it should not be assumed 
that CiCBR and BfCBR are necessarily activated by the endocannabinoids 2-AG and anandamide in 
vivo. The G-protein coupled receptors in mammals that are most closely related CB1 and CB2 are 
activated by other lipid signalling molecules – the lysophosphoplipids (114). Therefore, whilst we 
cannot assume that CiCBR and BfCBR are activated by the endocannabinoids 2-AG and 
anandamide, it seems reasonable to assume that these receptors are activated in vivo by 
endocannabinoid/lysophospholipid-like lipid signalling molecules. Thus, determining the identity of 
endogenous ligands for CiCBR and BfCBR is of great interest because it may shed light on how and 
when CB1/CB2-type receptors acquired their property of binding 2-AG and anandamide. 
 Although the pharmacological properties of CiCBR and BfCBR are unknown, some insights 
into the physiological roles of CiCBR have been obtained by investigation of the distribution CiCBR 
expression in Ciona intestinalis using specific antibodies that bind to the C-terminal tail of the 
receptor. These immunocytochemical studies revealed that the ~46 kDa CiCBR protein is 
concentrated in the cerebral ganglion of Ciona, which is located between the inhalent and exhalent 
siphons that confer on this species and other sea squirts a filter-feeding lifestyle. Furthermore, 
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CiCBR-immunoreactivity is localised in a dense meshwork of neuronal processes in the neuropile of 
the cerebral ganglion. CiCBR-immunoreactivity is also present in the axons and axon terminals of 
neurons that project via peripheral nerves over and around the internal surfaces of the inhalent and 
exhalent siphons (115), a pattern of expression consistent with behavioural effects of cannabinoids 
on siphon activity in Ciona (116). 
The axonal targeting of CiCBR in Ciona is intriguing because of its similarity to CB1 
receptor localisation in mammalian CB1-expressing neurons. It suggests that CiCBR may have a 
similar role to CB1 receptors by acting as an axonal regulator of neurotransmitter release. 
Furthermore, it implies that the role of CB1 receptors as presynaptic regulators of neurotransmitter 
release may be very ancient, preceding the gene duplication that gave rise to CB1 and CB2 receptors 
and dating back at least as far as the common ancestor of vertebrates and urochordates. What isn’t 
yet known is the molecular identity of neurotransmitter(s) or neurohormone(s) that are released by 
CiCBR-expressing neurons in Ciona. Is CiCBR expressed in GABAergic and/or glutamatergic 
neurons, as in mammals, or is CiCBR expressed in other types of neurons such as aminergic or 
peptidergic neurons? These are questions that need to be addressed if we are to gain an 
understanding of the physiological roles of CiCBR in Ciona. It would also be interesting to 
determine if BfCBR is expressed by neurons and targeted to axon terminals in Branchiostoma 
floridae. If it is, then this would indicate that the axonal targeting of CB1-type receptors that is seen 
in vertebrates can be traced back to the common ancestor of all extant chordates. 
 It is important to note that because CiCBR and BfCBR are co-orthologs of CB1-type and 
CB2-type cannabinoid receptors, then these receptors in invertebrate chordates may have both CB1-
like and CB2-like functional properties. It is of interest, therefore, that CiCBR is not only expressed 
in neurons but is also present in hemocytes in Ciona (117), which may be indicative of an ancient 
CB2-like role in regulation of immunological processes. Thus, we can imagine a scenario where in 
the invertebrate chordate ancestor of vertebrates a CiCBR/BfCBR-like protein may have had both 
CB1-type and CB2-type functions and following duplication of the gene encoding a CiCBR/BfCBR-
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like protein the duplicated receptors diverged and acquired their more specific CB1-type and CB2-
type functions. Clearly this is speculative but it provides a rationale for further investigation of the 
physiological roles of CiCBR and BfCBR and the physiological roles of CB1-type and CB2-type 
cannabinoid receptors in non-mammalian vertebrates.       
 
(c) Neurobiology of non-CB1/CB2 mediated endocannabinoid signalling in invertebrates 
 
 Whilst CB1/CB2-type receptors do not occur in the majority of invertebrates, as highlighted 
above, the biochemical pathways for biosynthesis/inactivation of 2-AG and anandamide occur 
throughout the animal kingdom. Therefore, it is of interest to review evidence of non-CB1/CB2 
mediated endocannabinoid signalling in the nervous systems of invertebrates. 
 
(i) Non-chordate deuterostomes - echinoderms and hemichordates 
 Effects of cannabinoids and endocannabinoids on fertilisation in the sea urchin 
Strongylocentrotus purpuratus (118) and the occurrence of an endocannabinoid-like signalling 
system in embryonic and larval sea urchins (Buznikov et al. 2010) have been reported. Furthermore, 
opportunities to investigate the existence and functions of endocannabinoid-like signalling systems 
in echinoderms and hemichordates have been facilitated recently by sequencing of the 
transcriptomes/genomes of the sea urchin Strongylocentrotus purpuratus and the hemichordate 
Saccoglossus kowalevskii (119-121). 
 
(ii) Lophotrochozoan protostomian invertebrates – annelids 
 Investigation of a putative endocannabinoid-like signalling system in annelids has largely 
focussed on the medicinal leech Hirudo medicinalis, which is a well-established model system in 
neurobiology. In 1997, Stefano et al. reported the sequence of a putative leech cDNA encoding a 
partial (153 amino-acids) protein sequence sharing significant similarity with mammalian CB1   
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cannabinoid receptors (122). However, subsequent analysis of the sequence revealed that it was 
chimeric, with a central region sharing 98% identity with the bovine adrenocorticotropic hormone 
(ACTH) receptor and outer regions sharing 65-68% identity with mammalian CB1   receptors (123). 
Horizontal transfer of bovine DNA to leeches that feed on bovine blood was offered as a possible 
explanation for this unusual sequence (123) but perhaps a more likely explanation is that the 
sequence is an artefact (1). More recently, the genome of the leech Hellobdella robusta has been 
sequenced (http://genome.jgi-psf.org/Helro1) and analysis of the genomic sequence data does not 
reveal the presence of any CB1-like genes, consistent with analysis of genomic sequence data from 
other protostomian invertebrates. However, there is evidence that an endocannabinoid-like system 
may exist in leeches and other annelids. 
 Detection of binding sites for 3H-anandamide in cell membranes derived from the CNS of 
Hirudo medicinalis suggested the presence of putative receptors for this molecule (122), whilst 
binding sites for the cannabinoid 3H-CP55,940 have been detected in the nervous system of another 
annelid species, the earthworm Lumbricus terrestris (79). Moreover, the detection of both 
anandamide and 2-AG and associated enzymatic activities in extracts of leech ganglia indicates that 
the biosynthetic machinery for synthesis of these molecules exists in annelids (124). 
 Building upon these biochemical studies are a recent series of papers by Brian Burrell and 
colleagues that have provided evidence that an endocannabinoid signalling system modulates 
synaptic transmission in the leech Hirudo medicinalis. Li and Burrell found that in the polysynaptic 
pathway from touch-sensitive mechanosensory neurons (T) to S interneurons in Hirudo, long-term 
depression (LTD) of synaptic transmission is observed following low frequency electrical 
stimulation (1 Hz) for 450 s or 900 s. LTD elicited by 450 s low frequency stimulation was blocked 
by NMDA receptor antagonists but LTD elicited by 900 s low frequency stimulation was unaffected 
by NMDA receptor antagonists. Interestingly, LTD elicited by 900 s low frequency stimulation was 
blocked by the cannabinoid receptor antagonist AM251 and by the DAG lipase inhibitor RHC80267, 
suggesting the involvement of an endocannabinoid-like signalling mechanism in this particular form 
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of synaptic plasticity. Importantly, application of 2-AG or the cannabinoid receptor agonist CP-
55,940 induced LTD of the T-S synaptic pathway, providing further evidence of an 
endocannabinoid-like mechanism of synaptic plasticity in the leech (125). 
Further characterisation of this system has revealed that LTD elicited by 900 s low frequency 
stimulation requires activation of metabotropic serotonin receptors and is dependent on Ca2+ 
elevation in the S interneuron, mediated by voltage-gated Ca2+ channels and intracellular inositol 
triphosphate receptors. Furthermore, this particular form of LTD also involves stimulation of nitric 
oxide synthase and a decrease in cAMP signalling (126). However, because synaptic plasticity is 
being examined here in the context of a polysynaptic pathway, mechanistic interpretation of these 
findings is complicated. Nevertheless, given that CB1/CB2-type cannabinoid receptors do not exist in 
annelids and other protostomian invertebrates, these findings raise intriguing questions concerning 
the molecular nature of the putative receptors that mediate effects of endogenous or exogenous 2-AG 
(and other related lipids) in the nervous system of the leech. 
 Research on mammalian models has provided evidence that transient receptor potential 
vanilloid (TRPV)-type receptors are activated by endocannabinoids in vitro and mediate in vivo 
effects of endocannabinoids (72, 127). Thus, Burrell and colleagues have investigated TRPV-type 
receptors as potential mediators of endocannabinoid-dependent LTD in the leech nervous system. In 
the leech there are three types of cutaneous mechanosensory neurons: low threshold touch (T), 
moderate threshold pressure (P) and high threshold nociceptive (N) neurons, all of which synapse 
onto the longitudinal motor neuron (L cell), which controls contraction during whole-body 
shortening. Low-frequency stimulation of the T neurons induces heterosynaptic LTD of 
glutamatergic transmission at the N-to-L synapse and, importantly, Yuan and Burrell found that this 
was blocked by DAG lipase inhibitors and the TRPV antagonists capsazepine and SB 366791. 
Furthermore, application of 2-AG and the TRPV agonist capsaicin mimicked LTD at the N-to-L 
synapses and these effects of 2-AG and capsaicin were blocked by capsazepine. Pre-treatment with 
2-AG or capsaicin occluded subsequent expression of LTD induced by low-frequency stimulation. 
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Finally, presynaptic, but not postsynaptic, intracellular injection of capsazepine blocked both low-
frequency stimulation-induced and 2-AG-induced LTD, indicating that presynaptic TRPV-type 
receptors mediate LTD at the N-to-L synapse. Collectively, these findings indicate that low-
frequency stimulation of T neurons stimulates postsynaptic synthesis of 2-AG or a 2-AG-like 
molecule in L neurons, which then acts in a retrograde manner to inhibit heterosynaptic 
neurotransmitter release by N neurons via a TRPV-type receptor mediated mechanism (128). 
Evidence that presynaptic TRPV-type receptor mediated LTD may be a widespread 
mechanism of synaptic plasticity in the leech nervous system has been obtained in a subsequent 
study using the leech T-S synaptic pathway as a model preparation (129). LTD is induced when a 
spike train is triggered in the S cell 1-10 s prior to stimulation of the T cell and this is blocked by 
perfusion of the preparation with the cannabinoid receptor antagonist AM251 or the DAG lipase 
inhibitor RHC80267 and by injection of the DAG lipase inhibitor tetrahydrolipstatin into the S cell. 
Perfusion with the TRPV anatagonist capsazepine also blocked LTD induced by a spike train in the 
S cell 1-10 s prior to stimulation of the T cell. This effect of capsazepine was observed when it was 
injected into the T cell but not when it was injected into the S cell. Thus, it appears that mechanisms 
of LTD involving postsynaptic synthesis of 2-AG or 2-AG-like molecules by DAG lipase and 
presynaptic activation of TRPV-type receptors occur widely in the leech nervous system. These 
findings raise interest in determination of the molecular identity of the putative TRPV-type receptors 
that mediate LTD in the leech nervous system. This would enable investigation of the cellular 
distribution of these receptors in the leech nervous system and comparison of their molecular 
properties with mammalian TRPV receptors. Likewise, it would be interesting to investigate the 
expression of DAG lipases in the leech nervous system at a cellular and sub-cellular level to assess 
DAG lipases as potential sources of 2-AG or 2-AG-like molecules that mediate LTD via retrograde 
synaptic signalling mechanisms.   
The discovery of LTD mediated by 2-AG or 2-AG-like molecules and TRPV-type receptors 
in the leech nervous system suggest that endocannabinoid-mediated retrograde synaptic signalling is 
Page 25 of 40
http://mc.manuscriptcentral.com/issue-ptrsb
Submitted to Phil. Trans. R. Soc. B - Issue
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Evolution and Comparative Neurobiology  Maurice R. Elphick  
 
 26
an evolutionarily ancient mechanism that predates the origins of CB1/CB2-type cannabinoid 
receptors in chordates. If this is correct, these mechanisms of synaptic plasticity may also operate in 
the nervous systems of other invertebrates (see below). Thus, the findings of Burrell and colleagues 
have paved the way for further investigation of the function of endocannabinoid-type signalling 
mechanisms in the nervous systems of all animals, extending the scope for research on the 
comparative neurobiology of endocannabinoid signalling well beyond the phylum Chordata. 
 
(iii) Lophotrochozoan protostomian invertebrates – molluscs 
 There has been relatively little investigation of endocannabinoid-like signalling systems in 
molluscs. This is perhaps surprising given the importance of molluscs as model systems in 
neurobiology, in particular the gastropod species Aplysia californica and Lymnaea stagnalis (130). 
The discovery that an endocannabinoid-type signalling system mediates synaptic plasticty in the 
leech Hirudo medicinalis, as highlighted above, may act as a stimulus for researchers to investigate 
if similar mechanisms operate in molluscan species. 
Importantly, biochemical studies on bivalve molluscan species have revealed the presence of 
N-acylethanolamines, including anandamide, putative binding sites for anandamide and a FAAH-
like enzymatic activity (131, 132). Furthermore, transcriptomic/genomic sequence data are available 
for molluscan species, including the gastropod Aplysia californica (133) and the bivalve Crassostrea 
gigas (134). Therefore, identification of genes encoding proteins implicated in endocannabinoid 
signalling (e.g. DAG lipases, MAGL, NAPE-PLD, FAAH) is now feasible for molluscan species, 
which will facilitate detailed investigation of endocannabinoid-like signalling systems in molluscan 
species. 
    
(iv) Ecdysozoan protostomian invertebrates – nematodes 
 The nematode Caenorhabditis elegans was the first animal species to have its genome 
sequenced and analysis of this sequence provided the first evidence that CB1/CB2-type cannabinoid 
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receptors do not occur throughout animal kingdom (1). A gene encoding a G-protein coupled 
receptor (C02H7.2) that shares sequence similarity with CB1/CB2-type cannabinoid receptors is 
present in Caenorhabditis elegans, but analysis of its sequence indicates that it is not an ortholog (1, 
78). Nevertheless, binding sites for the cannabinoid 3H-CP-55,940 have been detected in the 
nematode Panagrellus redivivus, suggesting the presence of other non-CB1/CB2-type cannabinoid 
receptors in nematodes (79) 
 The presence of the endocannabinoids anandamide and 2-AG has been specifically 
investigated in nematodes by analysis of three species, Caenorhabditis elegans, Caenorhabditis 
briggsae and Pelodera str ngyloides and both anandamide and 2-AG were detected in all three 
species. However, anandamide and 2-AG were not detected in a mutant strain of Caenorhabditis 
elegans (fat-3) that lacks functional activity of the delta-6 desaturase enzyme required for synthesis 
of long chain polyunsaturated fatty acids (including arachidonic acid) (135).  
 Importantly, the physiological roles of anandamide and other N-acylethanolamines (NAEs) in 
C. elegans have recently been investigated, exploiting the use of techniques to manipulate expression 
of genes encoding enzymes involved in NAE metabolism. Suppression of FAAH using RNA 
interference (RNAi) or FAAH inhibitors (URB597) caused an increase in the levels of anandamide 
and other NAEs and overexpression of the faah-1 gene caused a decrease in levels of anandamide 
and other NAEs, demonstrating the importance of FAAH as a regulator NAEs in an invertebrate 
species (136). Furthermore, faah-1 overexpression caused a developmental delay that was rescued 
by faah-1 RNAi, indicating a role for NAEs in promotion of larval development in C. elegans. Peak 
levels of NAEs are detected during the second larval stage (L2) at which time animals are committed 
to reproductive growth, but NAE levels are reduced at L2 in animals committed to an alternative 
diapause stage (dauer) induced by dietary restriction. This suggested that NAEs may act as signals of 
an altered metabolic state and, consistent with this notion, exogenous application of the NAE 
eicosapentaenoyl ethanolamide (EPEA), and to a lesser extent anandamide, was found to rescue 
dauer formation. Worms overexpressing faah-1 also exhibited resistance to thermal stress and 
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increased adult lifespan, whereas application of EPEA caused a reduction in thermotolerance and 
lifespan, most strikingly in animals under dietary restriction. Collectively, the data reported by 
Lucanic et al. indicate that the effect of dietary restriction on lifespan extension is mediated, at least 
in part, by a reduction in NAE signaling. However, the mechanisms by which NAEs exert effects on 
lifespan in C. elegans are as yet unknown and therefore identification of NAE receptors in 
nematodes now represents a fascinating objective for the future. 
 
(v) Ecdysozoan protostomian invertebrates – arthropods 
 Sequencing of the genome of an arthropod species, the insect Drosophila melanogaster, 
provided key evidence that CB1/CB2-type cannabinoids receptors do not occur throughout the animal 
kingdom (1) and this has been supported by sequencing of other arthropod genomes. Nevertheless, 
binding studies using radiolabelled cannabinoids have revealed the presence of putative binding sites 
in a variety of arthropod species (79), although identification of membrane proteins that bind 
cannabinoids has yet to be accomplished for any arthropod species. Evidence that TRPV-type ion 
channels mediate effects of endocannabinoids in the nervous system of the leech Hirudo medicinalis 
(128) points to these proteins as potential endocannabinoid receptors in arthropods. It is noteworthy 
that the prototype for the TRP ion channel family was first discovered in Drosophila as a result of 
molecular analysis of the transient receptor potential (trp) mutant that has a defective 
phototransduction mechanism (137). Interestingly, analysis of phototransduction in Drosophila has 
revealed similarities with mechanisms of 2-AG biosynthesis. Thus, the photon-activated rhodopsin 
protein is coupled via G-proteins to stimulate activation of phospholipase C (PLC) and the 
diacylglycerols (DAGs) generated by PLC are substrates for a DAG lipase that is a homolog of the 
mammalian enzymes DAGLα and DAGLβ. The Drosophila DAG lipase mutant (inaE) is defective 
in photoreceptor responses to light and a DAG metabolite is thought to mediate phototransduction by 
activating TRP and/or TRP-like (TRPL) ion channels (138). However, the identity of the DAG 
metabolite that binds to and activates the TRP/TRPL phototransduction channels is not known, 
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although there is evidence that it may be a polyunsaturated fatty acid (PUFA) (137). This suggests 
the existence and activity of a MAG lipase in the phototransduction pathway, but one has yet to be 
identified. As highlighted above, Drosophila and other insects do not have an ortholog of the MAGL 
enzyme that has such a key role in 2-AG metabolism in mammals. Therefore other as yet 
uncharacterised enzymes may generate endogenous TRP/TRPL ligands from MAG substrates. 
 Interestingly, DAG lipase is not only expressed in Drosophila photoreceptors but is also 
expressed more widely in the brain (138). Therefore, investigation of the physiological roles of DAG 
lipase and its metabolites in the nervous system of Drosophila might be fruitful in revealing the 
existence of an endocannabinoid-like signalling system that regulates synaptic activity in insects and 
other arthropods.  
 
(vi) Cnidarians 
 Cnidarians are considered to be the most primitive animals with nervous systems and 
evidence of an endocannabinoid-like system in the hydrozoan Hydra viridis has been reported (139). 
Sequencing of the genomes Hydra magnipapillata and the anthozoan Nematostella vectensis (140, 
141) has presented new opportunities for molecular analysis of putative endocannabinoid signalling 
mechanisms in the simple nervous systems of these animals. 
 
 
5. CONCLUDING COMMENTS 
The value and importance of non-mammalian animals for cannabinoid research has been 
illustrated here with reference to studies on “model organisms” ranging from leeches to lampreys 
and from zebrafish to zebra finches. However, we should not look upon cannabinoid-related studies 
on non-mammalian animals solely from a utilitarian perspective. Research on the evolution and 
comparative neurobiology of endocannabinoid signalling is intrinsically interesting and there is great 
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potential to deepen our understanding of this aspect of nervous system function by revealing “the art 
of the possible” in the diverse branches of the tree of life. 
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